Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M109,303Revenue $M34,858Net Margin (%)44.2Altman Z-Score2.1
Enterprise Value $M124,774EPS $1.7Operating Margin %51.0Piotroski F-Score6
P/E(ttm)7.0Beneish M-Score-2.0Pre-tax Margin (%)52.1Higher ROA y-yY
Price/Book9.510-y EBITDA Growth Rate %0.5Quick Ratio1.0Cash flow > EarningsN
Price/Sales3.15-y EBITDA Growth Rate %-5.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow24.8y-y EBITDA Growth Rate %62.7ROA % (ttm)23.4Higher Current Ratio y-yY
Dividend Yield %5.6PEG--ROE % (ttm)173Less Shares Outstanding y-yY
Payout Ratio %38.0Shares Outstanding M2,415ROIC % (ttm)53.3Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKCharles Brandes 2015-03-31 Add0.38%$41.68 - $48.81
($45.86)
$ 45.26-1%Add 18.20%3,879,073
GSKNWQ Managers 2015-03-31 Add0.14%$41.68 - $48.81
($45.86)
$ 45.26-1%Add 123.03%456,380
GSKKahn Brothers 2015-03-31 Add0.06%$41.68 - $48.81
($45.86)
$ 45.26-1%Add 14.12%58,200
GSKDodge & Cox 2015-03-31 Reduce-0.02%$41.68 - $48.81
($45.86)
$ 45.26-1%Reduce 2.18%23,436,551
GSKHOTCHKIS & WILEY 2015-03-31 Add0.01%$41.68 - $48.81
($45.86)
$ 45.26-1%Add 0.73%12,302,975
GSKJoel Greenblatt 2015-03-31 Add$41.68 - $48.81
($45.86)
$ 45.26-1%Add 0.41%83,578
GSKKen Fisher 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 45.26-1%Reduce 0.07%10,757,080
GSKTweedy Browne 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 45.26-1%Reduce 2.19%131,346
GSKDodge & Cox 2014-12-31 Reduce-0.64%$41.3 - $47.14
($44.76)
$ 45.261%Reduce 37.91%23,959,301
GSKHOTCHKIS & WILEY 2014-12-31 Add0.21%$41.3 - $47.14
($44.76)
$ 45.261%Add 13.04%12,213,885
GSKDavid Dreman 2014-12-31 Sold Out -0.01%$41.3 - $47.14
($44.77)
$ 45.261%Sold Out0
GSKDodge & Cox 2014-09-30 Reduce-1.11%$46.29 - $54.52
($49.01)
$ 45.26-8%Reduce 35.93%38,589,161
GSKHOTCHKIS & WILEY 2014-09-30 Add0.98%$46.29 - $54.52
($49.01)
$ 45.26-8%Add 118.31%10,804,564
GSKCharles Brandes 2014-09-30 Add0.56%$46.29 - $54.52
($49.01)
$ 45.26-8%Add 36.63%3,415,717
GSKKahn Brothers 2014-09-30 Buy 0.38%$46.29 - $54.52
($49.01)
$ 45.26-8%New holding51,000
GSKNWQ Managers 2014-09-30 Add0.03%$46.29 - $54.52
($49.01)
$ 45.26-8%Add 39.82%208,125
GSKDavid Dreman 2014-09-30 Buy 0.01%$46.29 - $54.52
($49.01)
$ 45.26-8%New holding1,328
GSKHOTCHKIS & WILEY 2014-06-30 Add0.93%$51.55 - $56.39
($54.16)
$ 45.26-16%Add 13358.60%4,949,118
GSKJohn Rogers 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 45.26-16%Add 49.33%988,772
GSKCharles Brandes 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 45.26-16%Add 15.52%2,500,048
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22105.73view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14114.1view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29755.58view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12277.17view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14223.29view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12277.17view

Press Releases about GSK :

    Quarterly/Annual Reports about GSK:

      News about GSK:

      Articles On GuruFocus.com
      Hotchkis & Wiley Large Cap Value Fund Q1 2015 Commentary May 22 2015 
      Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer May 22 2015 
      9 International Dividend Dogs With Upside Potential May 22 2015 
      Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
      Baxter Takes The Acquisition Route To Grow In The Oncology Segment May 14 2015 
      Tweedy Browne's Stocks With High Growing Yield May 11 2015 
      Taking a Closer Look at GlaxoSmithKline Apr 22 2015 
      British Stock Picks From Gurus During Q4 Mar 24 2015 
      Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
      Bestinfond Adds More Than a Dozen Foreign Stocks to Portfolio Mar 06 2015 

      More From Other Websites
      Investors prepared to give Sir Andrew Witty time to revive GSK May 24 2015
      Would Pfizer Buying GlaxoSmithKline Make Sense? May 22 2015
      Who are Gilead Sciences' (GILD) main competitors? May 22 2015
      Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or AstraZeneca plc? May 22 2015
      GSK submits Japan regulatory application for mepolizumab in severe eosinophilic asthma May 22 2015
      All Eyes on Pfizer as Shareholders Await the Mega-Deal: Real M&A May 21 2015
      How a "PfizerKline" would impact the Triangle May 21 2015
      $5.6B In Fines Against Major Banks Seems Like A Lot. Here's Why It Won't Deter Corporate Crime. May 20 2015
      Takeover talk sends FTSE higher May 20 2015
      GSK unmoved by broker talk of takeover May 20 2015
      Pfizer Would Benefit From Glaxo Takeover, Deutsche Bank Says May 20 2015
      What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Royal Dutch Shell Plc And... May 20 2015
      New Study Shows Inner-City Asthma Care Program Reduces Student Absenteeism by up to 20 Percent May 19 2015
      3 Stocks That Should Keep Delivering The Goods: GlaxoSmithKline plc, Lloyds Banking Group PLC &... May 19 2015
      As Bioquell plc Surges, Should You Dump It To Invest In GlaxoSmithKline plc? May 18 2015
      Cramer: Next week jam-packed with retail earnings May 15 2015
      Beat A Volatile FTSE 100 With GlaxoSmithKline plc, Smith & Nephew plc, WPP PLC And Glencore PLC May 15 2015
      Emergent BioSolutions, Glaxo Initiate Ebola Vaccine Study - Analyst Blog May 14 2015
      FTSE 100 finds its footing as Draghi backs eurozone stimulus May 14 2015
      FTSE ends higher; 3i Group leads after strong earnings May 14 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK